Megestrol Acetate Suspension
Product Images NDC 69339-160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 69339-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cup Label (Cup Label)

Cup Label (Cup Label)
Megestrol Acetate oral suspension label indicating a 10 mL delivered dose and the NDC 69339-160-01. The label states "Rx Only" and includes instructions to shake the suspension well before dosing, as well as a stability use note. The labeler is Dash Pharmaceuticals LLC, located in Upper Saddle River, NJ.*
FDA Label Image

Chemical Formula (Megestrol Formula)

Chemical Formula (Megestrol Formula)
Chemical structure of megestrol acetate. The diagram shows the molecular formula with labeled atoms and bonds representing the steroid derivative compound megestrol acetate, as indicated by the accompanying text.*
FDA Label Image

Trial 1 (Megestrol Trial 1)

Trial 1 (Megestrol Trial 1)
A line graph labeled 'TRIAL 1' showing mean weight change in pounds over 12 weeks, comparing different doses of Megestrol Acetate (800 mg, 400 mg, 100 mg) and placebo. The x-axis represents weeks (0, 4, 8, 12), and the y-axis shows mean weight change ranging from -3 to 12 pounds. The 800 mg line shows the greatest weight gain, followed by 400 mg, 100 mg, and placebo.*
FDA Label Image

Trial 2 (Megestrol Trial 2)

Trial 2 (Megestrol Trial 2)
A line graph titled "TRIAL 2" illustrating mean weight change in pounds over 12 weeks. The x-axis shows weeks (0, 4, 8, 12) and the y-axis shows mean weight change ranging from -3 to 12 pounds. Two data lines are shown: one for 800 mg treatment, which increases steadily to about 12 pounds at 12 weeks, and one for placebo, which decreases slightly to below zero by 12 weeks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.